Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| N-(1,3-Benzodioxol-5-yl)-2-[5-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-methylpyrazol-3-yl]oxyacetamide | IC50 | 38.0 [1] | |
| Caffeine | Ki | 20500.0 [1] | |
| 8-Cyclopentyl-1,3-dipropylxanthine | IC50 | 3.8 [1] | |
| 8-Cyclopentyl-1,3-dipropylxanthine | Ki | 51.0 [1], 1000.0 [2] | |
| 4-{2-[(7-Amino-2-Furan-2-Yl[1,2,4]triazolo[1,5-A][1,3,5]triazin-5-Yl)amino]ethyl}phenol | IC50 | 48.0 [1], 51.0 [2], 94.9 [3] | |
MLA | "Quest Database™ Adenosine A2b receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 6 Dec. 2025, https://www.aatbio.com/data-sets/adenosine-a2b-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 6). Quest Database™ Adenosine A2b receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/adenosine-a2b-receptor-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |